Current aspects in surgical treatment of benign adrenal cystic lesions

PURPOSE: To determine the safety and efficacy of retroperitoneal endoscopic adrenalectomy for benign cystic adrenal lesions. PATIENTS AND METHODS: 4 patients underwent retroperitoneal endoscopic adrenalectomy of benign cystic adrenal lesions at our center between March-September 2006. RESULTS: Retroperitoneal endoscopic adrenalectomy was successfully performed in all patents, no conversion was needed. The mean operative time was 60 minutes (range 45-90 min) and no complications were observed. The average hospital stay was 2 days. Neither clinical, no US-scan recurrence was observed on the first month postoperativelly. CONCLUSIONS: Retroperitoneal endoscopic adrenalectomy is a safe and efficacious procedure that offers a favorable minimally invasive alternative for the treatment of benign cystic adrenal lesions.